US equities |
NVDA $239.42 ▲+2.34% SPCX $168.26 ▲+5.85% MU $1,059.44 ▼-1.44% TSLA $380.98 ▲+2.80% MSFT $527.30 ▲+1.89% SNDK $1,691.50 ▼-1.66% INTC $116.37 ▼-2.48% META $742.93 ▲+2.04%
FinancialContent

Latest News about ARYD

Recent news which mentions ARYD

Stocks That Hit 52-Week Lows On Friday
Tickers ACR ALRM ARYD ATIP
Tags Options PULM LPSN
From Benzinga
Gene Therapy Player Amicus Therapeutics Terminates SPAC Merger, Shares Fall
Tickers ARYD FOLD
Tags News Market News Guidance
From Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
Tickers ABCL ADGI AGIO ARYD
Tags NTRA General TVTX
From Benzinga
Perceptive Advisors-Backed SPAC To Acquire Amicus's Gene Therapy Business
Tickers ARYD FOLD
Tags Health Care Briefs gene therapy
From Benzinga
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
Tickers ABBV ADXN AGTC AKYA
Tags RNXT EDIT GBS
From Benzinga